Literature DB >> 24993094

Prognostic effect of p53 expression in patients with completely resected colorectal cancer.

Bin-Wei Liu1, Yang Liu, Jun-Ru Liu, Zhong-Xu Feng, Tong Liu.   

Abstract

The p53 protein is closely involved in the carcinogenesis of many kinds of cancers. Though the prognostic role of p53 expression for the survival of colorectal cancer (CRC) patients has been preliminarily identified, the prognostic effect of p53 expression in patients with completely resected CRC is still unclear. Therefore, a retrospective cohort study was performed to assess the prognostic role of p53 expression for overall survival in patients with completely resected CRC. A total of 153 patients (mean age 50.9 years) with completely resected CRC was finally included in the retrospective cohort study. Kaplan-Meier product-limit methods and log-rank test were used to estimate overall survival distribution and test the difference. In addition, multivariable analysis by Cox regression model was also used to test the prognostic role of p53 expression on overall survival by adjusting for other confounding factors. Of those 153 CRC patients, 62 (40.5 %) were positive for p53 protein expression in the tumor tissues. The log-rank test showed that there was an obvious difference in the overall survival between the p53-positive group and the p53-negative group (P < 0.001). Multivariable analysis by Cox regression model further showed that p53 protein expression was an independent predictor of shorter overall survival in patients with completely resected CRC (hazard ratio [HR] = 1.77; 95 % confidence interval [95 % CI] 1.15-2.71, P = 0.009). Therefore, p53 protein expression in the tumor tissue is an independent predictor of shorter overall survival in patients with completely resected CRC.

Entities:  

Mesh:

Substances:

Year:  2014        PMID: 24993094     DOI: 10.1007/s13277-014-2219-z

Source DB:  PubMed          Journal:  Tumour Biol        ISSN: 1010-4283


  24 in total

1.  Prognostic significance of mucin and p53 expression in stage IB non-small cell lung cancer: a laboratory companion study to CALGB 9633.

Authors:  Stephen L Graziano; Lin Gu; Xiaofei Wang; Arthur H Tatum; Robin T Vollmer; Gary M Strauss; Robert Kratzke; Arkadiusz Z Dudek; Everett E Vokes; Mark R Green
Journal:  J Thorac Oncol       Date:  2010-06       Impact factor: 15.609

2.  Increases in p53 expression induce CTGF synthesis by mouse and human hepatocytes and result in liver fibrosis in mice.

Authors:  Takahiro Kodama; Tetsuo Takehara; Hayato Hikita; Satoshi Shimizu; Minoru Shigekawa; Hinako Tsunematsu; Wei Li; Takuya Miyagi; Atsushi Hosui; Tomohide Tatsumi; Hisashi Ishida; Tatsuya Kanto; Naoki Hiramatsu; Satoshi Kubota; Masaharu Takigawa; Yoshito Tomimaru; Akira Tomokuni; Hiroaki Nagano; Yuichiro Doki; Masaki Mori; Norio Hayashi
Journal:  J Clin Invest       Date:  2011-07-11       Impact factor: 14.808

3.  p63 and p53 expression in extranodal NK/T cell lymphoma, nasal type.

Authors:  Ziyin Ye; Qinghua Cao; Gang Niu; Yingjie Liang; Yongdong Liu; Lili Jiang; Xiaoling Yu; Anjia Han
Journal:  J Clin Pathol       Date:  2013-04-27       Impact factor: 3.411

4.  Artemisinin inhibits gastric cancer cell proliferation through upregulation of p53.

Authors:  Hong-Tao Zhang; Yun-Long Wang; Jie Zhang; Qin-Xian Zhang
Journal:  Tumour Biol       Date:  2014-02

Review 5.  Colorectal cancer.

Authors:  David Cunningham; Wendy Atkin; Heinz-Josef Lenz; Henry T Lynch; Bruce Minsky; Bernard Nordlinger; Naureen Starling
Journal:  Lancet       Date:  2010-03-20       Impact factor: 79.321

6.  Impact of p53 expression and microsatellite instability on stage III colon cancer disease-free survival in patients treated by 5-fluorouracil and leucovorin with or without oxaliplatin.

Authors:  A Zaanan; P Cuilliere-Dartigues; A Guilloux; Y Parc; C Louvet; A de Gramont; E Tiret; S Dumont; B Gayet; P Validire; J-F Fléjou; A Duval; F Praz
Journal:  Ann Oncol       Date:  2009-10-15       Impact factor: 32.976

7.  P-Glycoprotein/MDR1 regulates pokemon gene transcription through p53 expression in human breast cancer cells.

Authors:  Shengnan He; Feng Liu; Zhenhua Xie; Xuyu Zu; Wei Xu; Yuyang Jiang
Journal:  Int J Mol Sci       Date:  2010-08-27       Impact factor: 5.923

8.  Modulation of microRNA processing by p53.

Authors:  Hiroshi I Suzuki; Kaoru Yamagata; Koichi Sugimoto; Takashi Iwamoto; Shigeaki Kato; Kohei Miyazono
Journal:  Nature       Date:  2009-07-23       Impact factor: 49.962

9.  Prognostic significance of p53 expression in malignant bone tumors: a meta-analysis.

Authors:  Liangdong Jiang; Cheng Tao; Aiyong He
Journal:  Tumour Biol       Date:  2013-01-23

10.  Stage-specific sensitivity to p53 restoration during lung cancer progression.

Authors:  David M Feldser; Kamena K Kostova; Monte M Winslow; Sarah E Taylor; Chris Cashman; Charles A Whittaker; Francisco J Sanchez-Rivera; Rebecca Resnick; Roderick Bronson; Michael T Hemann; Tyler Jacks
Journal:  Nature       Date:  2010-11-25       Impact factor: 49.962

View more
  6 in total

1.  Combined detection of the expression of Nm23-H1 and p53 is correlated with survival rates of patients with stage II and III colorectal cancer.

Authors:  Yinying Wu; Yi Li; Xiaoai Zhao; Danfeng Dong; Chunhui Tang; Enxiao Li; Qianqian Geng
Journal:  Oncol Lett       Date:  2016-11-23       Impact factor: 2.967

2.  MICAL2 Mediates p53 Ubiquitin Degradation through Oxidating p53 Methionine 40 and 160 and Promotes Colorectal Cancer Malignance.

Authors:  Jinping Lu; Yuejin Li; Yuanzhong Wu; Shan Zhou; Chaojun Duan; Zigang Dong; Tiebang Kang; Faqing Tang
Journal:  Theranostics       Date:  2018-10-22       Impact factor: 11.556

3.  MNAT1 is overexpressed in colorectal cancer and mediates p53 ubiquitin-degradation to promote colorectal cancer malignance.

Authors:  Shan Zhou; Jinping Lu; Yuejin Li; Chan Chen; Yongqiang Cai; Gongjun Tan; Zhengke Peng; Zhenlin Zhang; Zigang Dong; Tiebang Kang; Faqing Tang
Journal:  J Exp Clin Cancer Res       Date:  2018-11-26

4.  P53 Is Involved in a Three-Dimensional Architecture-Mediated Decrease in Chemosensitivity in Colon Cancer.

Authors:  Jianming He; Xi Liang; Fen Luo; Xuedan Chen; Xueqing Xu; Fengchao Wang; Zhenping Zhang
Journal:  J Cancer       Date:  2016-04-29       Impact factor: 4.207

5.  Prognostic implications of EGFR protein expression in sporadic colorectal tumors: Correlation with copy number status, mRNA levels and miRNA regulation.

Authors:  Sofía Del Carmen; Luís Antonio Corchete; Ruth Gervas; Alba Rodriguez; María Garcia; José Antonio Álcazar; Jacinto García; Oscar Bengoechea; Luis Muñoz-Bellvis; José María Sayagués; Mar Abad
Journal:  Sci Rep       Date:  2020-03-13       Impact factor: 4.379

6.  Ring finger protein 19A is overexpressed in non-small cell lung cancer and mediates p53 ubiquitin-degradation to promote cancer growth.

Authors:  Yu Cheng; Yujiao Hu; Huanxi Wang; Zhi Zhao; Xizi Jiang; Yao Zhang; Jiameng Zhang; Yue Tong; Xueshan Qiu
Journal:  J Cell Mol Med       Date:  2021-06-29       Impact factor: 5.310

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.